Jung Cassie

CIK 00019601541 companyWARREN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001960154

Recent Transactions

30 trades

Exercise of In-Money
Aquestive Therapeutics, Inc.$AQST
Warrant (Right to Buy)
2026-09-03−4,587→ 0 total
Exercise of In-Money
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-09-03$0.96/sh+4,587→ 206,833 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-05-05$4.18/sh−72,734→ 202,246 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-03-10$4.17/sh−45,791→ 274,980 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2026-03-09+42,500→ 42,500 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-03-09+80,000→ 320,771 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-10-15$3.10/sh+25,000→ 308,346 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2025-10-15−25,000→ 0 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-10-15$7.01/sh−67,575→ 240,771 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-09-04$0.71/sh+25,000→ 345,526 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-09-04$5.00/sh−62,180→ 283,346 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2025-09-04−25,000→ 0 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2025-09-04−25,000→ 0 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-09-04$3.15/sh+25,000→ 320,526 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-10$2.54/sh−2,182→ 295,526 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-09$2.65/sh−7,997→ 297,708 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-07+80,000→ 313,066 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-07$2.65/sh−7,361→ 305,705 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2025-03-07+40,000→ 40,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2025-03-07+60,000→ 60,000 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-11-26$4.87/sh−44→ 0 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-10$4.88/sh−1,132→ 237,754 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-09$4.88/sh−8,300→ 238,886 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-09$4.88/sh−14,120→ 233,066 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2024-03-07+50,625→ 50,625 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-07+101,250→ 247,186 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2023-08-09+55,000→ 55,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2023-05-05+55,000→ 55,000 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2023-03-10−1,365→ 145,936 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2023-03-09+110,000→ 146,747 total

Companies

Aquestive Therapeutics, Inc.
Chief Operating Officer
$AQST

Recent Filings

Address

C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE

WARREN, NJ, 07059

View on SEC.gov